Registered drugs

You can find information about a therapy by entering a name or keyword in the search box and/or refine your search by selecting one of the categories below.
Therapies with the icon Book icon are more extended.


Cabozantinib (Cabometyx) is a cancer medicine used to treat adults with advanced renal cell carcinoma who have been previously treated with a type of cancer medicine called a ‘vascular endothelial growth factor (VEGF) inhibitor’

Radium Ra 223 dichloride

Radium RA 223 dichloride (xofigo) is an anticancer drug used to treat prostate cancer with metastases to the bones after they had hormonal treatment. It delivers radiation to bone tumors.


Pomalidomide is the active substance in Imnovid®. It is used in combination with dexamethasone (an anti-inflammatory medicine) to treat multiple myeloma (a cancer of the bone marrow). It is used in adults who have received at least two prior therapies, including both lenalidomide and bortezomib, and whose disease progressed after the last treatment.


The active substance in Iclusig®, ponatinib, belongs to a group of medicines called ‘tyrosine kinase inhibitors’. These compounds act by blocking enzymes known as tyrosine kinases.


Regorafenib (Stivarga) is used to treat metastatic colorectal cancer (cancer of the bowel and rectum that has spread to other parts of the body).

Trifluridine & Tipiracil

Trifluridine & Tipiracil (Lonsurf) is a cancer medicine used to treat adults with metastatic colorectal cancer (cancer of the large bowel that has spread to other parts of the body). It is used in patients who have already been treated with, or who cannot be given, other available treatments including chemotherapy based on medicines called fluoropyrimidines, oxaliplatin or irinotecan and treatment with other cancer medicines known as anti-VEGF and anti-EGFR.

Talimogene laherparepvec

Talimogene laherparepvec (Imlygic) is a cancer medicine used to treat adults with melanoma (a type of skin cancer) that cannot be surgically removed and that has spread to other parts of the body (but not to bone, lung, brain and other internal organs).


Sonidegib (Odomzo) is a cancer medicine used to treat adults with basal cell carcinoma (a type of skin cancer) which is locally advanced (has started to spread nearby) and which cannot be treated either by surgery or by radiotherapy.


Obinotuzumab (Gazyvaro) is a cancer medicine used to treat adult patients with previously untreated chronic lymphocytic leukaemia (CLL). CLL is a cancer of B-lymphocytes, a type of white blood cells; and follicular lymphoma (FL), another type of cancer of B-lymphocytes.


In squamous cell carcinoma of the head and neck, nimorazole is expected to work by acting as a ‘radiotherapy sensitiser’. This means that it is expected to make the cancer cells more sensitive to the effect of radiation, thus enhancing the effect of radiotherapy.